MyfembreeActive Ingredient(s): Estradiol + Norethindrone Acetate + Relugolix
FDA Approved: * May 26, 2021
Pharm Company: * MYOVANT SCIENCES
Category: Women's Health / Fertility
Relugolix/estradiol/norethisterone acetate (RGX/E2/NETA), sold under the brand name Myfembree, is a fixed-dose combination hormonal medication which is used for the treatment of heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women. It contains relugolix, an orally active gonadotropin-releasing hormone antagonist (GnRH antagonist), estradiol (E2), an estrogen, and norethisterone acetate (NETA), a progestin.[... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.